They assessed the diagnostic value of antineuronal antibody levels in the serum and cerebrospinal fluid of 38 SLE patients with and 29 without CNS involvement, in control patients (36 with non-SLE ...

Several approaches have been developed and tested as potential therapeutic agents in SLE in preclinical studies and in clinical trials. This article provides an overview on antibody-based ...

[74] Accordingly, some clinical trials have been initiated in SLE, using monoclonal antibodies against IFN-α and its receptor (IFNAR) or using an immune therapy to induce polyclonal anti-IFN-α ...

Medically reviewed by Stella Bard, MDSjögren’s antibody testing is done using a blood sample. It checks antibody levels, including anti-SS-A (also called anti-Ro) and anti-SS-B (also called anti-La).

PURPOSE:We sought to assess the nephritogenic antibody profile of patients with systemic lupus erythematosus (SLE), and to determine which antibodies were most useful in identifying patients at ...

The most common subtypes were acute CLE and chronic CLE. Upon further analyses, those with multiple CLE subtypes expressed statistically significant differences in rates of SLE diagnosis, history of ...

Systemic Lupus Erythematosus (SLE)—lupus for short—is a chronic, painful and debilitating disease in which the antibodies produced by the immune system mistakenly attack the body’s own tissues.

Systemic Lupus Erythematosus (SLE)—lupus for short—is a chronic, painful and debilitating disease in which the antibodies produced by the immune system mistakenly attack the body's own tissues.

Primary ovarian insufficiency was associated with a higher risk for autoimmune conditions including hypothyroidism and adrenal insufficiency.

Connective tissue diseases (CTDs) increase the risk for adverse maternal and fetal outcomes during pregnancy, with varying impacts across different CTD subtypes, according to study results published ...